Abstract
Inhibition of thromboxane synthetase potentiates the antihypertensive action of an angiotensin-converting enzyme inhibitor by a prostaglandin-dependent but kinin-independent mechanism.
N R Levens, D Cóte and G Ksander
Journal of Pharmacology and Experimental Therapeutics October 1991, 259 (1) 219-227;